Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antimicrobial Resistance of 1,113 Streptococcus pneumoniae Isolates from Patients with
Respiratory Tract Infections in Spain: Results of a 1-Year
(1996-1997) Multicenter Surveillance Study
Fernando
Baquero,1
José Angel
García-Rodríguez,2
Juan
García de
Lomas,3
Lorenzo
Aguilar,4,* and
The
Spanish Surveillance Group for Respiratory
Pathogens
Microbiology Department, Ramón y Cajal
Hospital,1 and
Medical Department,
SmithKline Beecham Pharmaceuticals,4 Madrid,
Microbiology Department, University Hospital,
Salamanca,2 and
Instituto Valenciano
de Microbiología, Valencia,3 Spain
Received 22 May 1998/Returned for modification 7 August
1998/Accepted 12 November 1998
A nationwide susceptibility surveillance of 1,113 Streptococcus pneumoniae isolates was carried out and found
the following percentages of resistance: cefuroxime, 46%; penicillin,
37%; macrolides, 33%; aminopenicillins, 24%; cefotaxime, 13%; and
ceftriaxone, 8%. A significant (P < 0.05)
seasonality pattern for
-lactam antibiotics was observed. Resistance
to macrolides was higher (P < 0.05) in
middle-ear samples. Higher percentages of resistance to cefuroxime and
macrolides were observed among penicillin-intermediate and -resistant
strains, whereas high frequencies of resistance to aminopenicillins and
expanded-spectrum cephalosporins were observed only among
penicillin-resistant strains.
*
Corresponding author. Mailing address: Departamento
Médico, SmithKline Beecham Pharmaceuticals, Valle de la
Fuenfría, 3, 28034 Madrid, Spain. Phone: 34-91-3345275. Fax:
34-91-3345141. E-mail: lorenzo.aguilar-alfaro{at}sb.com.
The members of the Spanish Surveillance Group for Respiratory
Pathogens are T. Jiménez de Anta and F. Marco, Clinic i
Provincial Hospital, Barcelona; E. Bouza and E. Cercenado, Gregorio
Marañón Hospital, Madrid; R. Gómez-Lus and
M. C. Rubio, University Hospital, Zaragoza; M. Gobernado and
N. Diosdado, La Fe Hospital, Valencia; I. Trujillano, University
Hospital, Salamanca; C. García Riestra and I. Rodríguez, Xeral de Galicia Hospital, Santiago de Compostela; M. de la Rosa and A. Martínez-Brocal, Virgen de las Nieves
Hospital, Granada; A. Gutierrez and A. García, La Paz Hospital,
Madrid; A. M. Martín Sánchez and F. Cañas,
Insular Hospital, Las Palmas; E. Perea and L. Martínez, Virgen
Macarena Hospital, Seville; G. Prats and F. Sanchez, Santa Creu i San
Pau Hospital, Barcelona; M. Casal and A. Ibarra, Reina Sofia Hospital,
Córdoba; R. Cisterna and A. Morla, Basurto Hospital, Bilbao;
A. C. Gómez-García and F. J. Blanco-Palenciano, Infanta Cristina Hospital, Badajoz; C. Gimeno and D. Navarro, Instituto Valenciano de Microbiología, Valencia; and
A. Torrellas, J. J. Granizo, R. Moreno, and R. Dal-Ré, SmithKline Beecham Pharmaceuticals, Madrid.
Antimicrobial Agents and Chemotherapy, February 1999, p. 357-359, Vol. 43, No. 2
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garvey, M. I., Piddock, L. J. V.
(2008). The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB. Antimicrob. Agents Chemother.
52: 1677-1685
[Abstract]
[Full Text]
-
Sevillano, D., Aguilar, L., Alou, L., Gimenez, M.-J., Echevarria, O., Cafini, F., Valero, E., Fenoll, A., Prieto, J.
(2006). Effects of antimicrobials on the competitive growth of Streptococcus pneumoniae: a pharmacodynamic in vitro model approach to selection of resistant populations. J Antimicrob Chemother
58: 794-801
[Abstract]
[Full Text]
-
Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group,
(2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother
57: 536-545
[Abstract]
[Full Text]
-
Nunes, S., Sa-Leao, R., Carrico, J., Alves, C. R., Mato, R., Avo, A. B., Saldanha, J., Almeida, J. S., Sanches, I. S., de Lencastre, H.
(2005). Trends in Drug Resistance, Serotypes, and Molecular Types of Streptococcus pneumoniae Colonizing Preschool-Age Children Attending Day Care Centers in Lisbon, Portugal: a Summary of 4 Years of Annual Surveillance. J. Clin. Microbiol.
43: 1285-1293
[Abstract]
[Full Text]
-
Fernandez, A., Cabellos, C., Tubau, F., Maiques, J. M., Domenech, A., Ribes, S., Linares, J., Viladrich, P. F., Gudiol, F.
(2005). Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother
55: 78-83
[Abstract]
[Full Text]
-
Oteo, J., Lazaro, E., de Abajo, F. J., Baquero, F., Campos, J., Spanish Members of the European Antimicrobial Resi,
(2004). Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates. J. Clin. Microbiol.
42: 5571-5577
[Abstract]
[Full Text]
-
Canton, R., Morosini, M., Enright, M. C., Morrissey, I.
(2003). Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother
52: 944-952
[Abstract]
[Full Text]
-
Reynolds, R., Shackcloth, J., Felmingham, D., MacGowan, A., on behalf of the BSAC Extended Working Party on Re,
(2003). Antimicrobial susceptibility of lower respiratory tract pathogens in Great Britain and Ireland 1999-2001 related to demographic and geographical factors: the BSAC Respiratory Resistance Surveillance Programme. J Antimicrob Chemother
52: 931-943
[Abstract]
[Full Text]
-
Mason, E. O. Jr., Lamberth, L. B., Wald, E. R., Bradley, J. S., Barson, W. J., Kaplan, S. L.
(2003). In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macrolides. Antimicrob. Agents Chemother.
47: 166-169
[Abstract]
[Full Text]
-
Bogaert, D., Ha, N. T., Sluijter, M., Lemmens, N., de Groot, R., Hermans, P. W. M.
(2002). Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam. J. Clin. Microbiol.
40: 3903-3908
[Abstract]
[Full Text]
-
Perez-Trallero, E., Garcia-Rey, C., Martin-Sanchez, A. M., Aguilar, L., Garcia-de-Lomas, J., Ruiz, J.
(2002). Activities of Six Different Quinolones against Clinical Respiratory Isolates of Streptococcus pneumoniae with Reduced Susceptibility to Ciprofloxacin in Spain. Antimicrob. Agents Chemother.
46: 2665-2667
[Abstract]
[Full Text]
-
Casal, J., Aguilar, L., Jado, I., Yuste, J., Gimenez, M. J., Prieto, J., Fenoll, A.
(2002). Effects of Specific Antibodies against Streptococcus pneumoniae on Pharmacodynamic Parameters of {beta}-Lactams in a Mouse Sepsis Model. Antimicrob. Agents Chemother.
46: 1340-1344
[Abstract]
[Full Text]
-
Del Grosso, M., Iannelli, F., Messina, C., Santagati, M., Petrosillo, N., Stefani, S., Pozzi, G., Pantosti, A.
(2002). Macrolide Efflux Genes mef(A) and mef(E) Are Carried by Different Genetic Elements in Streptococcus pneumoniae. J. Clin. Microbiol.
40: 774-778
[Abstract]
[Full Text]
-
Balcabao, I. P., Alou, L., Aguilar, L., Gomez-Lus, M. L., Gimenez, M. J., Prieto, J.
(2001). Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones. J Antimicrob Chemother
48: 907-909
[Abstract]
[Full Text]
-
Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C., Bouza, E., Aguilar, L., Garcia-de-Lomas, J., Baquero, F., The Spanish Surveillance Group for Respiratory Pat,
(2001). Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes Isolates and Their Ecological Relationships: Results of a 1-Year (1998-1999) Multicenter Surveillance Study in Spain. Antimicrob. Agents Chemother.
45: 3334-3340
[Abstract]
[Full Text]
-
Alou, L., Ramirez, M., Garcia-Rey, C., Prieto, J., de Lencastre, H.
(2001). Streptococcus pneumoniae Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Clonal Diversity and Appearance of Ciprofloxacin-Resistant Epidemic Clones. Antimicrob. Agents Chemother.
45: 2955-2957
[Abstract]
[Full Text]
-
de Neeling, A. J., Overbeek, B. P., Horrevorts, A. M., Ligtvoet, E. E. J., Goettsch, W. G.
(2001). Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999. J Antimicrob Chemother
48: 441-444
[Abstract]
[Full Text]
-
Morosini, M.-I., Canton, R., Loza, E., Negri, M.-C., Galan, J.-C., Almaraz, F., Baquero, F.
(2001). In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms. Antimicrob. Agents Chemother.
45: 2427-2431
[Abstract]
[Full Text]
-
Bogaert, D., Engelen, M. N., Timmers-Reker, A. J. M., Elzenaar, K. P., Peerbooms, P. G. H., Coutinho, R. A., de Groot, R., Hermans, P. W. M.
(2001). Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study. J. Clin. Microbiol.
39: 3316-3320
[Abstract]
[Full Text]
-
Hoban, D. J., Wierzbowski, A. K., Nichol, K., Zhanel, G. G.
(2001). Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998-1999: Prevalence of mef(A) and erm(B) and Susceptibilities to Ketolides. Antimicrob. Agents Chemother.
45: 2147-2150
[Abstract]
[Full Text]
-
Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E.
(2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother.
45: 1889-1891
[Abstract]
[Full Text]
-
Garcia-Garrote, F., Cercenado, E., Martin-Pedroviejo, J., Cuevas, O., Bouza, E.
(2001). Comparative in vitro activity of the new quinolone gemifloxacin (SB-265805) with other fluoroquinolones against respiratory tract pathogens. J Antimicrob Chemother
47: 681-684
[Abstract]
[Full Text]
-
Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Mauriz, Y., Kahn, J.
(2001). Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis. Antimicrob. Agents Chemother.
45: 1037-1042
[Abstract]
[Full Text]
-
Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E.
(2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother.
45: 636-638
[Abstract]
[Full Text]
-
Oteo, J., Alos, J. I., Gomez-Garces, J. L.
(2001). Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study. J Antimicrob Chemother
47: 215-218
[Abstract]
[Full Text]
-
Syrogiannopoulos, G. A., Grivea, I. N., Tait-Kamradt, A., Katopodis, G. D., Beratis, N. G., Sutcliffe, J., Appelbaum, P. C., Davies, T. A.
(2001). Identification of an erm(A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrob. Agents Chemother.
45: 342-344
[Abstract]
[Full Text]
-
García-Rey, C., Aguilar, L., Baquero, F., Spanish Surveillance Group for Respiratory Pathoge,
(2000). Influences of Different Factors on Prevalence of Ciprofloxacin Resistance in Streptococcus pneumoniae in Spain. Antimicrob. Agents Chemother.
44: 3481-3482
[Full Text]
-
Bogaert, D., Syrogiannopoulos, G. A., Grivea, I. N., de Groot, R., Beratis, N. G., Hermans, P. W. M.
(2000). Molecular Epidemiology of Penicillin-Nonsusceptible Streptococcus pneumoniae among Children in Greece. J. Clin. Microbiol.
38: 4361-4366
[Abstract]
[Full Text]
-
Granizo, J. J., Aguilar, L., Casal, J., Garcia-Rey, C., Dal-Re, R., Baquero, F.
(2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and {beta}-lactam consumption in Spain (1979-1997). J Antimicrob Chemother
46: 767-773
[Abstract]
[Full Text]
-
Marco, F., Bouza, E., Garcia-de-Lomas, J., Aguilar, L.
(2000). Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. J Antimicrob Chemother
46: 557-564
[Abstract]
[Full Text]
-
Betriu, C., Redondo, M., Palau, M. L., Sánchez, A., Gómez, M., Culebras, E., Boloix, A., Picazo, J. J.
(2000). Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci. Antimicrob. Agents Chemother.
44: 1838-1841
[Abstract]
[Full Text]
-
Hsueh, P.-R., Liu, Y.-C., Shyr, J.-M., Wu, T.-L., Yan, J.-J., Wu, J.-J., Leu, H.-S., Chuang, Y.-C., Yeu-Jen Lau, , Luh, K.-T.
(2000). Multicenter Surveillance of Antimicrobial Resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 Respiratory Season. Antimicrob. Agents Chemother.
44: 1342-1345
[Abstract]
[Full Text]
-
Heaton, V. J., Goldsmith, C. E., Ambler, J. E., Fisher, L. M.
(1999). Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance Mechanisms. Antimicrob. Agents Chemother.
43: 2998-3000
[Abstract]
[Full Text]
-
Oster, P., Zanchi, A., Cresti, S., Lattanzi, M., Montagnani, F., Cellesi, C., Rossolini, G. M.
(1999). Patterns of Macrolide Resistance Determinants among Community-Acquired Streptococcus pneumoniae Isolates over a 5-Year Period of Decreased Macrolide Susceptibility Rates. Antimicrob. Agents Chemother.
43: 2510-2512
[Abstract]
[Full Text]
-
Gómez-Lus, R., Granizo, J. J., Aguilar, L., Bouza, E., Gutierrez, A., García-de-Lomas, J., Spanish Surveillance Group for Respiratory Pathoge,
(1999). Is There an Ecological Relationship between Rates of Antibiotic Resistance of Species of the Genus Streptococcus?. J. Clin. Microbiol.
37: 3384-3386
[Abstract]
[Full Text]